Abstract: Compression injury to the spinal cord (SC) results in vascular changes affecting the severity of the primary damage of the spinal cord. The recruitment of bone marrow (BM)-derived cells contribute to revascularization and tissue regeneration in a wide range of ischemic pathologies. Involvement of these cells in the vascular repair process has been investigated in an animal model of spinal cord injury (SCI).
INTRODUCTION
Microvascular changes are a prominent feature in traumatic spinal cord injury (SCI) contributing to secondary injury and causing further functional deterioration of the patient. Physical and molecular disruption of the sensitive capillary networks within the highly vascularized spinal cord tissue participate in secondary injury mediated by a complex cascade of deleterious events that leads to further degenerative damage beyond the site of initial injury [1] . For the management of these traumatic lesions, the intrinsic processes of revascularization have to be explored. Several recent reports have shown that revascularization accomplished by vasculogenesis and angiogenesis supports wound healing after trauma [2, 3] . In angiogenesis sprouting vessels originate from pre-existing blood vessels, whereas vasculogenesis is a process of neovascularisation implemented by differentiating progenitor cells. The newly formed vessels are subsequently stabilized by mural cells that build the outer sheath surrounding the endothelial cells.
healing [4] [5] [6] and to revascularization in a wide range of ischemic pathologies [7] [8] [9] [10] [11] . However, reports about endothelial differentiation from BM-derived hematopoietic cells in various neovascularization models are controversial, since some of them indicate that the stem cells give rise to pericytes but not to vascular endothelial cells [12, 13] . This controversy may be due to differences in tissues and neovascularization models. In addition, diversity of pericytes on the morphological and on the molecular level even leads to more confusion [14, 15] .
BM-derived cells are capable of entering the central nervous system (CNS) under physiological conditions in mice as shown by [16] . Moreover, it has been shown that BM-derived cells rapidly infiltrate the brain after cerebral ischemia, giving rise to microglia [17, 18] , endothelial cells [19, 20] , and pericytes [21] . So far, a possible contribution of endogenous BM-derived progenitor cells in the repair of damaged microvessels of the traumatized spinal cord has not been extensively studied.
Whereas most reports focus on the contribution of hematopoietic progenitor cells in wound healing and neovascularisation, less is known about vessel stabilization in the process of vessel growth and remodelling. Therefore, increased attention has to be paid also to pericytes and their interaction with endothelial cells after traumatic CNS injury as they belong to the neurovascular unit in the CNS.
The aim of this study was to elucidate the occurrence of putative endogenous BM-derived stem cells in the spinal cord after a mild compression injury in rats. We analyzed the temporal appearance of CD133+ and CD34+ cells at the lesion site in order to reveal the emergence of alleged BMderived stem cells with repopulating potential. In addition, the time-dependent expression of stromal cell derived factor-1 (SDF-1) and its receptor CXCR4 was investigated since SDF-1/CXCR4 interaction has been shown to be critical for the mobilization and homing of stem cells [22] . Our results from histology and quantitative RT-PCR show that the markers are differentially regulated after SCI and are expressed by different cell types that could not be attributed clearly to progenitor cells of bone marrow origin. However, our data indicate the abundance of resident CD133+ pericytes in the spinal cord reacting to SCI. Hence, our results provide new insight in the participation of mural cells in vascular rearrangement in the intricate secondary injury process.
MATERIAL AND METHODS

Animals and Surgical Procedures
All animal experiments were approved by the local Animal Welfare Committee and were in compliance with the Swiss Guidelines for the Care and Use of Animals.
For SCI, adult male Wistar rats (250-300g, Biological Research Laboratories Ltd, Füllinsdorf, Switzerland) were anesthetized with 3% isoflurane (Baxter AG, Volketswil, Switzerland) in a gas mixture of 30% oxygen and 70% nitrogen through a nose mask. Body temperature was maintained at 37°C using a rectal probe coupled with a homeothermic blanket system (Harvard Apparatus, Holliston, MA, USA) during anesthesia. Following laminectomy, the spinal cord at thoracic levels T8-T9 was compressed using a microvascular clip with a closing force of 20 g (Biemer, Mediwar AG, Switzerland) for 15 sec. Surgical controls consisted of sham animals that received a laminectomy but were not subjected to spinal cord injury. Subsequently, the incision was closed in two layers and the animals were allowed to recover from anesthesia and returned to their home cage. After survival times of 2, 6, 24, 48, 72 hours, 1, 2, 3, and 4 weeks, animals were deeply anesthetized with isoflurane, decapitated, and spinal cords were immediately dissected out, embedded in O.C.T. compound (Sakura, NL), and slowly frozen at -80°C.
Antibodies
The following antibodies and dilutions were used: rabbit anti-CD133 from Santa Cruz Biotechnology (clone H-284, sc-30220, USA) diluted 1/50; rat endothelial antibody-1 (RECA-1) raised in mouse from Abcam (ab22492, UK) diluted 1/250, mouse anti--smooth muscle actin (SMA) from Chemicon International (CBL171, USA) used at 1/500; goat anti-CD34 from R&D Systems (AF4117, USA) diluted 1/50; mouse anti-CD11b from Chemicon International (OX-42, CBL 1512) diluted 1/50; rabbit anti-CXCR4 from Abcam (ab2074) diluted 1/50; rabbit anti-SDF-1 from Santa Cruz Biotechnology (sc-28876) diluted 1/100; mouse antiglial fibrillary acidic protein (GFAP) from Sigma (clone G-A-5, G 38893) diluted 1/500; the nuclear marker DAPI (4',6'-diamidine-2-phenylindole) was diluted 1/10000. Cy2 and Cy3-coupled secondary antibodies were all from Jackson ImmunoResearch Laboratories (USA) and diluted 1/300.
Immunohistology
Horizontal spinal cord sections (10 m) from sham and injured rats after 2 days, 2 and 4 weeks were cut in a cryostat and mounted on Super Frost Plus slides (Menzel, Braunschweig, Germany). After fixation with acetone at 4°C for 10 min (for antibodies against CD133, -SMA, and RECA-1) or 4% formalin for 1 hour (for antibodies against CD34 (except for the costaining with CD133, for which acetone was used), CD11b, CXCR4, SDF-1, and GFAP), sections were rinsed in PBS, incubated with blocking buffer (20% normal goat or donkey serum in PBS containing 0.2% Triton-X100, (PBS-T)) for 20 min and then incubated overnight at 4°C with the primary antibodies. After incubation, sections were washing with PBS, and incubated for 30 minutes at room temperature with the corresponding fluorescent dye-coupled secondary antibodies. Sections were washed in PBS and covered with Fluorosave (Calbiochem) and stored at 4°C until processing. Sections were observed and photographed using a Leica DMRE microscope equipped with a F-view camera (Soft Imaging System, Germany).
Quantification of the fluorescent signals was performed in regions of interest (ROI) surrounding the lesion sites (n=3 rats for each time point). The pictures of the ROI (0.35 mm 2 , 25X magnification) were binarized and then analyzed with the AnalySIS Image computer program (AnalySIS, Soft Imaging System), and expressed as percentages of the ROI (% of ROI). 
Gene Expression Analysis
Spinal cord tissues (5 mm long segments containing the compression site) from injured rats (n=3) and sham-operated rats (n=3) for all time points indicated above were dissected out and fresh frozen on dry ice. Total RNA was extracted using the RNeasy Lipid Tissue Kit (Qiagen, Hombrechtikon, Switzerland) including homogenization of the tissues with the Dispomix® Drive (Medic Tools AG, Zug, Switzerland). Following analysis of the RNA integrity by Experion Electrophoresis (Bio-Rad Laboratories AG, Reinach, Switzerland), 1 g of RNA was transcribed into cDNA with Random Hexamers using First Strand cDNA Synthesis Kit for RT-PCR (Roche, Rotkreuz, Switzerland). For the absolute quantification of mRNA, gene-specific primers were designed from unique site over exon-intron junctions to prevent amplification of genomic DNA ( Table 1) . Real-time PCR was carried out with the CFX96 Thermal Cycler (BioRad) using iQ SYBR Green Supermix (Bio-Rad). Amounts of RNA were calculated with relative standard curves for all mRNA of interest, and 60S ribosomal protein L13A was used for normalization. The gene expression in injured spinal cords were expressed as fold changes compared to shamoperated tissues.
Statistical Analysis
Data are presented as mean ± standard deviation (SD). For the comparison of the fluorescent signals and the means of gene expression in injured and sham-operated tissues a non-parametric Mann-Whitney U-Test was used. The level of statistical significance was set by a P value <0.05.
The experimental set-up for all experiments is summarized in Table 2 .
RESULTS
Expression of CD133 in the Normal and Injured Spinal Cord
To resolve the question of a potential appearence of BMderived CD133+ stem cells after acute SCI, the CD133 protein expression was analyzed by immunohistological staining. The analysis revealed the presence of CD133+ structures in the non-injured as well as in the injured spinal cord (Fig. 1A) . The number of CD133+ structures was markedly reduced 2 days post-SCI compared to shamoperated tissue (Fig. 1A, a and b) . This decrease affected the lesion area and the surrounding parenchyma likewise. However, the CD133+ cells reappeared in the spinal tissues after 2 and 4 weeks post-SCI (Fig. 1A, c and d) , except in the cavities formed at these time points. Quantification of the fluorescent signal confirmed these observations (Fig. 1B) . CD133 protein expression was significantly reduced after 2 days, and significantly increased after 2 weeks. The quantitative analysis of the CD133 gene expression was performed in a time course from 2 h to 4 weeks following injury (Fig. 1C) . Compared to the expression in shamoperated tissues, CD133 mRNA expression was significantly downregulated from 6 h until 1 week post-SCI and returned to the sham-expression level thereafter. A transient significant decrease in CD133 mRNA expression level was observed after 3 weeks.
Colocalization of CD133 with Endothelial Cell Marker, Smooth Muscle Actin and CD34
To characterize the cells expressing CD133 in the spinal cord, colocalization studies of CD133 with markers specific for endothelial cells and smooth muscle cells/pericytes were performed (Fig. 2) . Endothelial cells were identified with RECA-1 in the luminal area of the vessels, while CD133+ cells were located in the abluminal zone, surrounding the endothelial cells ( Fig. 2a and b) . The costaining with -SMA and CD133 showed colocalization of both proteins in arterioles ( Fig. 2c and d) . In few vessels, however, only -SMA was expressed without CD133. Higher magnification ( Fig. 2d and inlet) illustrates the ring-like morphology of the double-stained cells and the inhomogeneous expression of both proteins. Further typification of these cells by costaining of CD133 and CD34 revealed that CD34+ cells are localized in the lumen of the vessels, without any indication of overlapping CD133/CD34 expression (Fig. 2e) . 
Effect of Spinal Cord Injury on -SMA Expression
The spinal sections immunostained for -SMA after several time points post-SCI showed strong reduction of -SMA+ cells after 2 days compared to controls (Fig. 3A, a  and b) . More -SMA+ structures were detectable in the spinal cord signal after 2 and 4 weeks post-SCI, except in the lesion areas devoid of -SMA+ cells (Fig. 3A, c and d) . A higher magnification (Fig. 3A, e) illustrates the disposition of -SMA+ smooth muscle cells around arterioles in the normal spinal cord, whereas smaller capillaries are devoid of -SMA expression. Signal quantification in the tissue surrounding the compression site revealed significant less -SMA+ vessels after 2 days and 2 weeks (Fig. 3B) . The signal after 4 weeks was similar to the one in the sham-operated animals. The gene expression analysis showed strong variations over the experimental observation period, with significant downregulations of -SMA mRNA expression after 3 days and 4 weeks only (Fig. 3C) .
Spinal Expression of CD34 and Colocalization with CD11b
Anti-CD34 antibody recognized endothelial cells in capillaries and arterioles that were homogeneously distributed in the normal spinal cord (Fig. 4A, a) . At the compression site, CD34+ vascular structures were disorganized and swollen and some areas were devoid of blood vessels 2 days after injury (Fig. 4A, c) . CD34+ cells invaded the surrounding of the lesion after 2 and 4 weeks, with the formation of big clusters of positive cells (Fig. 4A, e and g) . In order to identify these CD34+ cells, costaining with CD11b, a marker of macrophages/monocytes was performed. In the shamoperated spinal cord, few CD11b+ microglia cells were identified (Fig. 4A, b) . At day 2 after injury, numerous CD11b+ cells showing macrophage-like morphology were present in the compressed area (Fig. 4A, d ), but these cells did not express CD34. In contrast, after 2 and 4 weeks post-SCI, the majority of the CD11b+ cells also expressed CD34 (Fig. 4A, f and h) . The differential CD34 gene expression analysis indicated that CD34 mRNA was significantly downregulated during the first 2 days after injury, starting at 6 h post-SCI. A radical switch in the CD34 gene expression occurred at day 3, with significant elevation lasting for the following weeks post-SCI (Fig. 4B) .
Expression of the Mobilization Factor SDF-1 and its Receptor CXCR4
Immunofluorescent staining of the spinal cords showed only rare SDF-1+ cell nuclei in the sham-operated animals (Fig. 5A, a) in contrast to the situation observed 2 days post- SCI in which no specific staining was found (Fig. 5A, b) . Some SDF-1+ cells appeared around the lesion site 2 weeks post-SCI, and their number increased around the cavity 4 weeks after injury (Fig. 5A, c and d) . In addition to these cells, the vascular walls of blood vessels also expressed SDF-1 at this time point (Fig. 5A, e) . Costaining for GFAP, a specific astrocytic marker, and for SDF-1 showed clear colocalization of both proteins in astrocytes (Fig. 5A, f,  arrowheads) at close vicinity of the cavity 4 weeks post-SCI. The SDF-1 receptor CXCR4 was also expressed in the spinal cord (Fig. 5B) . CXCR4-expressing cells were localized in arterioles and in some few cell nuclei in the sham-operated spinal cord (Fig. 5B, a) . There were no visible changes in the expression of CXCR4 with time after injury, except for 4 weeks post-SCI, where additional single cells and capillaries-like structures showed CXCR4 reactivity near the cavity (Fig. 5B, b, arrowheads) . The temporal gene expression analysis of the mobilization factor SDF-1 revealed a transient decrease of mRNA expression in the injured spinal cord compared to sham-operated controls in the period from 6 h to 3 days post-SCI (Fig. 5C ). Significant differences were obtained during the period of 24 h until 3 days after the insult. However, the differential expression pattern showed escalating augmentation thereafter, with significantly higher changes in injured tissues relative to controls 2 and 4 weeks post-SCI. SCI induced an increase in CXCR4 gene expression after 2 days that remained significantly higher compared to controls until the end of the observation period (Fig.  5D) .
Comparison of the Time Course of CD133, CD34, SDF-1 and CXCR4 Gene Expression
By combining the temporal gene expression graphs of CD133, CD34, SDF-1, and CXCR4, clear differences in the expression patterns could be observed (Fig. 6) . Although the expression of CD133, CD34, and SDF-1 were first repressed after SCI, the expression of CXCR4 was induced as soon as 2 days after SCI. The increase in CD34 expression after 3 days was followed by the ones of SDF-1 and CD133 after 1 week post-SCI.
DISCUSSION
In this study we demonstrated that spinal cord intrinsic cells express CD133 and CD34, two markers related to BMderived progenitor cells, which were clearly present on different cell types. The CD133+ cells, associated with the vasculature, were responsive to a spinal cord injury induced by mild compression. Gene expression analysis as well as immunostaining of CD133 revealed a downregulation of this marker in the injured tissue shortly after SCI, returning to normal values after 4 weeks post-SCI. The expression of CD34 initially observed on endothelial cells dramatically increased from the 3 rd day post-injury. After this time point this marker was found on endothelial cells, reactive microglia and infiltrating macrophages. The expression of the stem cell mobilizing factor SDF-1 was first downregulated and then stimulated significantly only after 3 weeks by cells localized around the spinal cord lesion. However, its receptor CXCR4 was overexpressed over a long period starting at 2 days after injury.
In contrast to our first hypothesis, we found no clear indication of a migration of BM-derived stem cells into the injured spinal cord during the 4 weeks observation period that could induce neovascularization of the traumatized tissue. Neovascularization involves complex signaling mechanisms, with a high degree of spatial and temporal coordinations among multiple cell types [23] . Successful revascularization of ischemic spinal cord tissue must not only involve the formation of new vessels but also their stabilization and maturation through recruitment of support cells and reconstitution of blood-brain barrier (BBB) properties. The correct association of all the cells constituting the neu-rovascular unit (microvascular endothelium, astrocytes, peri-cytes, and neurons) is essential for the health and function of the CNS.
Here we report that abundant CD133+ cells are present in the vasculature of the uninjured and injured spinal cord tissue likewise. By our immunohistochemical analysis of the blood vessels, it became apparent that CD133+ vessel-like structures were positive for -SMA. However, not all vascular -SMA+ cells expressed CD133. According to their expression pattern and localization, the CD133+ cells could be identified as pericytes surrounding arterioles. This is supported by the discovery that pericytes surrounding arterioles are routinely -SMA positive, whereas those located near brain capillaries are mostly -SMA negative [24, 25] . Pericytes account a heterogeneous population of cells lacking a clear ontogeny and adequate specific markers. These cells exhibit a dynamic versatility of cellular plasticity [25] [26] [27] [28] as they may change from one cell type to another by fusion [29] and/or transdifferentiation processes [25] . Very recently, native pericytes were described as multipotent stem cells in the adult brain and in other tissues [24, 25] representing a pool for at least some mesenchymal stem cells [25] and it is speculated that they potentially act as progenitor cells in regenerative processes and tissue repair. However, a bone marrow origin of pericytes and transdifferentiation of endothelial cells into pericytes have also been demonstrated during postnatal vascular repair and in adult angiogenesis [28, [30] [31] [32] . The finding of CD133 expression by adult perivascular cells in the CNS is intriguing, since to the best of our knowledge it has never been described so far. The discovery of pericytes expressing this bone marrow stem cell-related marker supports the notion of a possible contribution of bone marrow-derived pericytes in the pathological process of secondary injury after SCI.
In our temporal analysis, the CD133 and -SMA protein expression after SCI did not coincide, what could be partially explained by pericyte plasticity.
Following experimental traumatic brain injury, the majority of the pericytes undergo a degenerative process in response to vascular injury. This loss results in endothelial cell apoptosis and causes destabilization of the microvasculature [33] . Therefore, pericyte recruitment is likely to play an important role in vascular remodelling [34] . It has been suggested that adult BM-derived precursors give rise to pericytes in neovascularization models [13, 21] . Furthermore, mobilized stem cells residing in the vasculogenic zone of large and middle-sized arteries and veins are considered to be a source of cells for vascular repair [35, 36] . Whether the initial decrease in CD133 expression after SCI followed by an increase are due to such degeneration preceding a subsequent local recruitment have to be explored in prospective investigations. Our data from the CD133 signal quantification support this hypothesis. Interestingly, the time point of elevated CD133 expression coincides with the stage of optimal improvement of locomotion previously measured in the same model of SCI [37] . Other BM-derived CD133+ vascular progenitor cells such as EPCs located at the luminal side of the vessels were not detectable in the spinal cord in the present study. The loss of CD133 when circulating EPCs transform into more mature endothelial cells makes it difficult to determine the origin of ECs in the adult tissue [38] .
SCI results in profound and immediate loss of blood vessels at the injury epicentre [39] . This vessel regression has been shown to be due to intense induction of apoptosis of endothelial cells [40] . Consistent with this observation, our data reveal rapid decrease in CD34 mRNA expression by endothelial cells during the first 2 days post-SCI, suggesting endothelial cell death. This could also be confirmed by our immunohistochemical analysis exhibiting CD34+ blood vessels displaying a peculiar morphology at this time point. However, our quantitative PCR analysis showed increasing levels of CD34 transcripts in the injured rat tissues starting by day 3. These CD34+ cells were accumulated at the lesion border and their rounded and ameboid morphology resembled resident or infiltrating monocytic cells, whose identity was confirmed by the co-expression of CD11b. Indeed, endogenous CNS-resident microglia as well as immigrant cells contribute to reactive microgliosis that accumulate at sites of injury [41] . It has been shown that proliferating CD11b+ microglia are induced to express high levels of CD34 [42] . However, BM-derived CD34+ cells are also able to differentiate into microglia [43] . It is therefore not possible to discriminate between these two options in order to explain the appearance of CD34+/CD11b+ cells in our study, and both processes may be present.
The chemokine SDF-1 has been shown to be critical for the recruitment of EPCs in models of ischemic neovascularization and for homing of stem cells [22] . SDF-1 is believed to bind exclusively to the chemokine receptor CXCR4 [44] . Both, CXCR4 and SDF-1 are activated at the transcriptional level by hypoxia [45, 46] , representing a key factor in the exacerbation of secondary injury after SCI. In the injured rat spinal cord tissues we found long-lasting upregulation of CXCR4 mRNA already 2 days after surgery. This finding is reflected by the broad range of cell types expressing this receptor such as peripheral blood cells, macrophages, microglia, neurons, astrocytes, pericytes, and vascular endothelial cells [47, 48] . Our immunohistological stainings showed also an increase in CXCR4 positive capillaries and arterioles after injury, probably as a consequence of the hypoxic stimuli in the tissues [49] . By gene expression analysis, we perceived a decrease of SDF-1 expression until day 3 post-injury escalating to increased values until the end of our experimental observation period. Our immunohistological results revealed that local reactive astrocytes and endothelial cells were the major sources for SDF-1 in the ischemic spinal lesion area observed 2 and 4 weeks post-SCI. These findings are in agreement with the results from Imitola and colleagues [50] showing an increase of SDF-1 expression by reactive astrocytes and blood vessels in ischemic area, but not in the contralateral hemisphere in a model of cerebral ischemia. However, the delayed induction of SDF-1 in the injured spinal cord tissue may impede efficient neovascularization, since cavity formation already started 2 weeks post-SCI.
Comparative temporal gene expression analysis of SDF-1 and CXCR4 exhibits no coherence between the two genes. Comparison of the variation in time between CD133 and SDF-1 revealed a corresponding trend of CD133 expression with the expression of SDF-1. Very recently, the impact of the SDF-1/CXCR4 axis on pericyte attraction was highlighted by reports describing the effect of SDF-1 on pericyte recruitment during cancerous vascular remodeling [51, 52] . Whether the effect of the SDF-1 on pericytes during the phase of secondary injury is executed by the chemokine of its own or in concert with other vessel stabilizing factors such as PDGF-BB as described lately [51] remains unclear. In contrast, the CD34 gene expression did not coincide with the SDF-1 expression, as CD34 mRNA was upregulated 4 days before the increase of SDF-1. This indicates that the initial increase of CD34 in the injured spinal cord may be independent of SDF-1. Although it has been suggested that SDF-1 is involved in the recruitment of several immune cells, as demonstrated for CD11b and CD14 expressing cells [51] , in our model however, CD11b cells were invading the injured tissue when the expression of SDF-1 was repressed.
CONCLUSION
This study provides new information on pericyte reactivity in the injured spinal cord. Both the pericyte subpopulation expressing CD133 and the mobilization factor SDF-1 were diminished during the first week of spinal cord secondary injury. Considering their role in angiogenesis and revascularization, spinal cord microvascular pericytes may represent an important target for future therapeutic strategies to maintain blood vessel integrity after SCI. Future effort may focus on the mobilization of CNS pericytes and induction of vasculogenic processes early after the trauma, since maintainance and rapid restoration of the local blood flow may assure cellular and functional integrity of the spinal cord.
